# ZAYVORA MATAB OS — Clinical Safety Audit Findings
**Document ID:** `CLIN-SAFE-2026-10-13`  
**Classification:** Confidential — Clinical Governance & Patient Safety  
**Scope:** Standalone Zayvora Matab OS Safety Engine & Clinical Preflight  
**Status:** AUDITED & CLINICALLY VERIFIED  

---

## 1. Executive Summary

Clinical safety is the foundational cornerstone of Zayvora Matab OS. In accordance with classical Unani Tibb principles (Ibn Sina's *Al-Qanun fi al-Tibb*, Kabir al-Din, Qarabadin-e-Qadri) and modern statutory pharmacovigilance (Drugs and Cosmetics Act Rule 161-B Schedule E(1)), the system operates an autonomous, deterministic, fail-closed Clinical Safety Firewall.

### Clinical Safety Scorecard
| Safety Dimension | Engine Status | Verification Mechanism |
| :--- | :--- | :--- |
| **Fail-Closed Architecture** | **VERIFIED PASS** | If safety preflight raises an unhandled exception or database error, prescription signing is blocked (`FAIL_CLOSED`). |
| **Schedule E(1) Toxic Botanical Checks** | **VERIFIED PASS** | Automatic detection of toxic botanical substances; mandatory verified `mudabbar` (detoxification) certificate and antidote formulation rules. |
| **Maximum Dosage Enforcements** | **VERIFIED PASS** | Enforces single-dose and cumulative daily dose limits based on authoritative Pharmacopoeia of Unani Medicine (UPI) monographs. |
| **Pregnancy & Lactation Contraindications** | **VERIFIED PASS** | Absolute blocking of abortifacient, emmenagogue, or teratogenic formulations in pregnant patients. |
| **Mizaj (Temperament) Discordance Alerts** | **VERIFIED PASS** | Detects hot/dry 3rd & 4th degree medicines prescribed against acute Bilious/Sanguine (Safrawi/Damwi) fevers and provides Musleh (corrective) recommendations. |
| **Herb-Herb & Herb-Drug Interactions** | **VERIFIED PASS** | Deterministic rule-based evaluation of cross-system botanical and allopathic interactions with structured severity ratings. |
| **Human Clinician Signature Requirement** | **VERIFIED PASS** | AI and algorithmic engines can never sign or dispense prescriptions. Mandatory clinician cryptographic PIN verification is enforced. |

---

## 2. Schedule E(1) Hazardous Herb Governance & Mudabbar Rules

### 2.1 Regulated Substances Monitored
The safety engine continuously tracks Indian Drugs and Cosmetics Act Schedule E(1) poisonous substances used in Unani medicine:
1. **Kuchla (*Strychnos nux-vomica*)**: Contains strychnine.
   - *Requirement:* Must be certified *Mudabbar* (detoxified by boiling in cow's milk or *Roghan-e-Zard*).
   - *Dosage Limit:* Maximum single dose 60 mg; daily maximum 120 mg.
   - *Antidote / Musleh:* Kateera, Samagh-e-Arabi, milk.
2. **Afiyun (*Papaver somniferum*)**: Contains morphine and codeine alkaloids.
   - *Requirement:* Restricted dispensing; requires explicit therapeutic rationale, maximum 3-day supply, and mandatory Musleh (Zafaran, Jund-e-Bedastar).
3. **Bhang / Charas (*Cannabis sativa*)**:
   - *Requirement:* Detoxified in almond oil / cow's ghee; strict age check (>18 years).
4. **Samm-ul-Far (Arsenic trioxide / Sankhiya)**:
   - *Requirement:* Strict metallic purification protocol; single dose strictly capped at 2 mg.

### 2.2 Audit Testing Findings
- **Unpurified Order Rejection:** When attempting to prescribe raw *Azaraqi (Kuchla)* without the `mudabbar=true` flag, the safety preflight halted checkout and returned a `LETHAL_CONTRAINDICATION` error.
- **Overdose Rejection:** Prescribing 200 mg of Mudabbar Kuchla immediately failed dosage boundary validation.

---

## 3. Herb-Herb and Herb-Drug Interaction Engine

### 3.1 Severity Classification Framework
Interactions are graded across five deterministic severity tiers:
1. **LETHAL / ABSOLUTE CONTRAINDICATION (Tier 1):** Immediate hard stop. Cannot be overridden even by clinician PIN. Prescription cannot be finalized. (e.g., Samm-ul-Far with incompatible mineral calces without detox).
2. **CRITICAL CLINICAL HAZARD (Tier 2):** Hard stop by default. Can only be overridden by a senior clinician (`CHIEF_TABIB` or authorized `TABIB`) submitting a documented clinical justification and entering their cryptographic PIN.
3. **MODERATE CAUTION (Tier 3):** Soft warning. Requires acknowledgement of therapeutic monitoring plan.
4. **MIZAJ DISCORDANCE (Tier 4):** Clinical advisory detailing temperament conflict and recommending specific Musleh (corrective botanical) and Badal (substitute botanical).
5. **INFORMATIONAL / SYNERGISTIC (Tier 5):** Helpful advisory noting positive synergistic bioavailability (e.g., Filfil Siyah / Piperine co-administration).

### 3.2 Tested Interaction Matrix Scenarios
- **Scenario A (Botanical Anticoagulant + Allopathic Anticoagulant):** Patient taking Warfarin prescribed high-dose *Zanjabeel (Zingiber officinale)* and *Ginkgo biloba*. System correctly generated a **Tier 2 Critical Clinical Hazard** warning for potentiated bleeding risk.
- **Scenario B (Classical Musleh Correction):** Prescribing *Zanjabeel* without *Honey/Badam* in a patient with excessive Safra (Yellow Bile). Engine raised a **Tier 4 Mizaj Alert** with recommendation to add *Shahad (Honey)*.

---

## 4. Patient-Specific Contraindications & Special Populations

### 4.1 Vulnerable Population Safeguards
| Population Segment | Enforced Clinical Constraint |
| :--- | :--- |
| **Pregnancy (Hamal)** | Complete block on emmenagogues (e.g., *Abhal*, *Murr Makki*, *Ushq*) and uterine stimulants. |
| **Lactation (Raza'at)** | Alerts on purgatives of the 3rd degree (*Saqmonia*, *Turbud*) excreted in breast milk. |
| **Pediatric (< 12 years)** | Strict weight-adjusted dosing formula (Young's / Clark's rule applied to Unani pharmacopoeia adult limits); prohibition of opium and cannabis derivatives. |
| **Geriatric (> 65 years)** | Renal and hepatic clearance advisory; recommendation of gentle digestive tonics (*Jawarish Kamuni*) over strong evacuants (*Munzij-o-Mushil*). |
| **Renal Impairment** | Alerts on high-oxalate botanicals and heavy metal *Kushtas* (calces). |

---

## 5. Clinician In-the-Loop & Anti-Automation Boundary

### 5.1 Prohibition of Autonomous AI Prescribing
- In compliance with Indian National Medical Commission (NMC) regulations and international digital health safety mandates, **no automated algorithm, rule-set, or LLM agent is permitted to write, approve, or dispense a clinical prescription**.
- All suggestions generated by clinical decision support tools (CDSS) are rendered as non-binding draft advisories.
- The prescription status remains `DRAFT` until a human clinician manually reviews the items, signs with their confidential 6-digit PIN, and commits the SHA-256 fingerprint into the audit trail.

---

## 6. Audit Trail for Safety Overrides

### 6.1 Tamper-Evident Safety Log
Every safety preflight execution is recorded in `safety_preflight_logs`:
- Unique `preflight_id` (UUIDv4)
- Linked `encounter_id` and `practitioner_id`
- Timestamp and input items hash
- Rules evaluated count and execution duration (milliseconds)
- Warnings detected count and severity breakdown
- If overridden: mandatory `override_reason` (min 20 characters) and clinician digital PIN verification hash.

---

## 7. Clinical Audit Sign-off
- **Safety Lead Auditor:** Dr. A. Qureshi, BUMS, MD (Unani) — Senior Clinical Consultant
- **Systems Engineering:** Lead Healthcare Systems Architect
- **Verdict:** The Clinical Safety Firewall is **APPROVED FOR CLINICAL GO-LIVE** under governed human-in-the-loop operation.
